COVID-19, Cancer Care and Prevention
COVID-19, Cancer Care and Prevention
复制标题
DOI：
10.1158/1940-6207.capr-20-0468
复制
发表时间：
2020-11-01
影响因子：
3.3
通讯作者：
DuBois, Raymond N.
中科院分区：
文献类型：
--
作者：
DuBois, Raymond N.
COVID-19大流行对我们的社会和美国的医疗保健服务产生了巨大影响。重要的是，在过去的4-5个月里，癌症的选择性手术和筛查检查被推迟或取消，这引起了人们对癌症风险或确诊患者未来发病率和结果的担忧。癌症领域的每个人都清楚，我们越早发现癌前病变或癌症，对患者的临床结果就越好。大多数医疗机构现在都制定了安全程序和指导方针，这大大降低了在其医疗机构接触期间病毒传播的风险。我们现在必须鼓励公众和癌症高危人群恢复正常的癌症筛查。
The COVID-19 pandemic has had an enormous impact on our society and healthcare delivery in the United States. Importantly, elective procedures and screening exams for cancer have been delayed or canceled over the past 4-5 months raising concerns over the future incidence and outcomes for those at risk or diagnosed with cancer. It is clear to everyone in the cancer field that the earlier we detect premalignant disease or cancer, the better the clinical outcome is for the patient. Most healthcare institutions have now put safety procedures and guidelines in place, which have dramatically reduced the risk of viral spread during encounters in their healthcare facilities. We must now encourage the public and those individuals at high risk for cancer to resume normal cancer screening.